Exosomal proteins in prostate cancer progression: from mechanisms to diagnostic and therapeutic applications
Prostate cancer (PCa) remains a leading cause of cancer death in men, and the limitations of prostate-specific antigen (PSA) testing continue to delay diagnosis and confound risk stratification.